Prevention of Mother-to-child Transmission of Hepatitis B Virus: a One Arm, Open Label Intervention Study to Estimate the Optimal Timing of Tenofovir (TDF) in Pregnancy
Latest Information Update: 08 Feb 2023
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 03 Feb 2023 Status changed from active, no longer recruiting to completed.
- 14 Oct 2022 Planned End Date changed from 31 Dec 2019 to 31 Jan 2023.
- 14 Oct 2022 Planned primary completion date changed from 31 Jul 2019 to 31 Jan 2023.